STERIS (STE) Stock Forecast & Price Target

$226.54 +0.68 (+0.30%)

As of 05/9/2025 03:59 PM Eastern

STERIS - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 5 Analyst Ratings

Sell
0

Hold
1

Buy
4

Based on 5 Wall Street analysts who have issued ratings for STERIS in the last 12 months, the stock has a consensus rating of "Buy." Out of the 5 analysts, 1 has given a hold rating, 3 have given a buy rating, and 1 has given a strong buy rating for STE.

Consensus Price Target

$258.75
14.22% Upside

According to the 5 analysts' twelve-month price targets for STERIS, the average price target is $258.75. The highest price target for STE is $265.00, while the lowest price target for STE is $240.00. The average price target represents a forecasted upside of 14.22% from the current price of $226.54.

Get the Latest News and Ratings for STE and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for STERIS and its competitors.

STE Analyst Ratings Over Time

Type	Current Forecast 5/11/24 to 5/11/25	1 Month Ago 4/11/24 to 4/11/25	3 Months Ago 2/11/24 to 2/10/25	1 Year Ago 5/12/23 to 5/11/24
Strong Buy	1 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	4 Buy rating(s)	4 Buy rating(s)	3 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$258.75	$258.75	$258.75	$241.60
Forecasted Upside	14.22% Upside	16.99% Upside	15.43% Upside	4.44% Upside
Consensus Rating	Buy	Moderate Buy	Moderate Buy	Moderate Buy

STE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

STE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

STERIS Stock vs. The Competition

Type	STERIS	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.81	2.54
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	14.22% Upside	4,490.76% Upside	16.98% Upside
News Sentiment Rating	Positive News See Recent STE News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
5/1/2025	Stephens 4 of 5 stars	S. Etoch Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
4/10/2025	JMP Securities 2 of 5 stars	David Turkaly Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Outperform	$265.00 ➝ $265.00	+20.94%
4/7/2025	Needham & Company LLC 2 of 5 stars	Mike Matson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
2/3/2025	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Bednar Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$260.00 ➝ $265.00	+21.26%
9/3/2024	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$255.00 ➝ $265.00	+9.11%
12/4/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Equal Weight ➝ Equal Weight	$225.00 ➝ $215.00	+5.65%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 04:20 AM ET.

Should I Buy STERIS Stock? STE Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, May 5, 2025. Please send any questions or comments about these STERIS pros and cons to contact@marketbeat.com.

STERIS
Bull Case

Here are some ways that investors could benefit from investing in STERIS plc:

STERIS plc has a strong return on equity of approximately 13.91%, indicating effective management and profitability in generating returns for shareholders.
The company reported earnings per share of $2.32 for the latest quarter, which, while slightly below analysts' expectations, reflects a solid performance in a competitive market.
Recent analyst ratings show a consensus of "Moderate Buy," with five analysts giving buy ratings, suggesting positive sentiment and potential for stock appreciation.
Current price targets from analysts range up to $265.00, indicating potential upside from the current stock price, which is around $258.75.
STERIS plc operates in the essential healthcare sector, providing infection prevention products and services, which are critical in maintaining health standards globally.

STERIS
Bear Case

Investors should be bearish about investing in STERIS plc for these reasons:

The company missed earnings expectations by a small margin, which could raise concerns about its ability to meet future financial targets.
Despite a generally positive outlook, one analyst has rated the stock as a hold, indicating some uncertainty about its short-term performance.
With a net margin of 8.66%, there may be concerns about profitability compared to competitors, which could affect investor confidence.
Market volatility and economic conditions can impact the healthcare sector, potentially affecting STERIS plc's performance and stock price.
Investors may be cautious due to the competitive landscape in the medical equipment industry, which could pressure margins and growth prospects.

STE Forecast - Frequently Asked Questions

: According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for STERIS is $258.75, with a high forecast of $265.00 and a low forecast of $240.00.
: 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last year. There is currently 1 hold rating, 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" STE shares.
: According to analysts, STERIS's stock has a predicted upside of 14.22% based on their 12-month stock forecasts.
: Over the previous 90 days, STERIS's stock had 1 upgrade by analysts.
: STERIS has been rated by research analysts at JMP Securities, Needham & Company LLC, and Stephens in the past 90 days.
: Analysts like STERIS more than other "medical" companies. The consensus rating for STERIS is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how STE compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:STE) was last updated on 5/11/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

STERIS (STE) Stock Forecast & Price Target